Nighttime screen use is hypothesized to attenuate the physiological nocturnal fall in blood pressure, contributing to the non-dipper phenotype in adolescents.
This narrative review proposes that intensive nighttime screen use, through mechanisms such as melatonin suppression and sympathetic activation, disrupts circadian control of the cardiovascular system, leading to a reduced nocturnal blood pressure dip (non-dipper phenotype). The paper positions 24-hour ambulatory blood pressure monitoring as the reference standard for detecting this at-risk phenotype and masked hypertension, which are invisible to office readings. The review integrates subclinical biomarkers and emerging wearable/AI tools into a proposed screening pathway.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Nighttime screen use is hypothesized to attenuate the physiological nocturnal fall in blood pressure, contributing to the non-dipper phenotype in adolescents. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Nighttime screen use is hypothesized to attenuate the physiological nocturnal fall in blood pressure, contributing to the non-dipper phenotype in adolescents.
This conclusion is most relevant to: Adolescents exposed to nighttime screen use.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Detecting the Non-Dipper Phenotype in Adolescents Exposed to Nighttime Screen Use-Digital Chronotoxicity as a Proposed Integrative Framework: A Narrative Review of Ambulatory Blood Pressure Monitoring, Subclinical Biomarkers, and Emerging Wearable and AI-Based Screening. (Diagnostics (Basel, Switzerland), 2026) —
How It Works
The proposed biological pathway:
- ▸Nighttime screen use suppresses melatonin
- ▸Sustained sympathetic and neuroendocrine activation occurs
- ▸Oxidative stress and metabolic dysregulation develop
- ▸Result: Attenuated nocturnal blood pressure fall, leading to non-dipper phenotype
Who Might Benefit
Evidence fit by population:
- ▸Adolescents exposed to nighttime screen use
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Narrative review, not a systematic review or meta-analysis, so evidence synthesis may be selective
- ▸The concept of 'digital chronotoxicity' is proposed but not empirically validated in this paper
- ▸No quantitative effect sizes or direct experimental data are provided
Frequently Asked Questions
What is digital chronotoxicity?▼
It is a proposed integrative concept that describes the disruptive effect of nighttime screen use on circadian control of the cardiovascular system, leading to chronic sleep loss and increased cardiovascular risk.
Why is the non-dipper phenotype important in adolescents?▼
The non-dipper phenotype, where nocturnal blood pressure does not fall sufficiently, is a predictor of early vascular aging and is invisible to office blood pressure measurements, making it a hidden risk factor.
How is the non-dipper phenotype detected?▼
It is detected using 24-hour ambulatory blood pressure monitoring (ABPM), which is positioned as the reference standard for identifying the at-risk phenotype and masked hypertension.
What are the proposed mechanisms linking screen use to non-dipping?▼
The mechanisms include melatonin suppression, sustained sympathetic and neuroendocrine activation, oxidative stress, and metabolic dysregulation, which together attenuate the physiological nocturnal blood pressure fall.
References
- 1.Tupu AE, Tudor SS, Tudor IM, Stefan CS, Munteanu AE, Nechita A. “Detecting the Non-Dipper Phenotype in Adolescents Exposed to Nighttime Screen Use-Digital Chronotoxicity as a Proposed Integrative Framework: A Narrative Review of Ambulatory Blood Pressure Monitoring, Subclinical Biomarkers, and Emerging Wearable and AI-Based Screening..” Diagnostics (Basel, Switzerland), 2026. PMID: 42587597 DOI: 10.3390/diagnostics16152355